EC Gynaecology

Menorrhagia, characterized by heavy or prolonged excessive menstrual bleeding, which is a common gynaecological health issue in women that can be cause for various pathophysiological conditions, including uterine cancer. In this mini review we attempted to establish a link between menorrhagia and endometrial cancer, highlighting the importance of understanding this connection for timely diagnosis and treatment of clinical manifestations. The cause of the menorrhagia can arise from hormonal disturbances, structural abnormalities, or any other systemic conditions, but it is also a potential health indicator of endometrial cancer, particularly in women over 40 or those which are associated with risk factors like obesity or a family history of gynaecological cancers. Early detection and diagnosis of uterine cancer is a crucial factor for effective management and improved treatment outcomes, and it often involves diagnostic clinical techniques such as pelvic ultrasounds, endometrial biopsies, and hysteroscopy. Understanding the symptoms of menorrhagia and its potential link with endometrial cancer signifies the need for state of the art medical investigations to assure the prompt and effective management of both benign and malignant conditions.

 Keywords: Menorrhagia; Uterine Cancer; Polycystic Ovary Syndrome (PCOS)

1. Warner PE., et al. “Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data”. American Journal of Obstetrics and Gynecology 5 (2004): 1216-1223.
2. Kumar S and Ghosh S. "Menorrhagia: A review of its causes and management”. International Journal of Reproduction, Contraception, Obstetrics and Gynecology5 (2018): 1724-1730.
3. American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 168: Heavy Menstrual Bleeding (2020).
4. Friedman CL and Gierach GL. "Endometrial Hyperplasia: An Update”. American Family Physician5 (2019): 307-312.
5. Khan KN and Nandi A. "Menorrhagia: A Review”. International Journal of Gynecology and Obstetrics1 (2020): 78-85.
6. Kahn SR and MacKinnon C. "Thyroid disorders and their effect on menstrual cycle patterns”. Obstetrics and Gynecology Clinics of North America2 (2020): 319-332.
7. Federici AB and Mancuso ME. "Von Willebrand disease: Diagnosis and management”. Hematology/Oncology Clinics of North America5 (2018): 829-846.
8. Pillai M. "Heavy menstrual bleeding and its impact on quality of life: A study among women in Kerala”. Journal of Obstetrics and Gynaecology5 (2019): 631-635.
9. Schrier SL. "Heavy menstrual bleeding and iron deficiency anemia: An underappreciated public health concern”. Journal of Women’s Health7 (2018): 845-853.
10. Lacey JV and Lubin JH. "Menstrual cycle characteristics and risk of endometrial cancer: A case-control study”. American Journal of Epidemiology3 (2015): 186-197.
11. Cohn DE and Schink JC. "Endometrial hyperplasia and endometrial cancer: Epidemiology and risk factors”. Journal of Clinical Oncology1 (2016): 100-109.
12. Huang CC and Nair S. "Understanding the causes of heavy menstrual bleeding: a clinical perspective”. Current Obstetrics and Gynecology Reports2 (2021): 67-74.
13. Fedele L and Parazzini F. "Heavy menstrual bleeding: An underestimated and often mismanaged health problem”. Reproductive Health1 (2019): 1-6.
14. Cote I and Rojas A. "Heavy menstrual bleeding: A clinical review”. American Family Physician10 (2015): 852-857.
15. Munro MG and Critchley HOD. "Menstrual disorders: A review”. Journal of Clinical Endocrinology and Metabolism6 (2017): 1852-1863.
16. "Practice Bulletin No. 168: Heavy Menstrual Bleeding”. Obstetrics and Gynecology 126.5 (2015): e143-e155.
17. Lacey JV and Lubin JH. "Menstrual cycle characteristics and risk of endometrial cancer: A case-control study”. American Journal of Epidemiology3 (2015): 186-197.
18. Munro MG and Critchley HOD. "Menstrual disorders: A review”. Journal of Clinical Endocrinology and Metabolism6 (2017): 1852-1863.
19. Ginsburg ES and Kauffman RP. "The role of progesterone in the menstrual cycle”. Clinical Obstetrics and Gynecology3 (2019): 493-504.
20. Vrachnis N and Kallipolitis G. "The role of endometrial polyps in abnormal uterine bleeding”. Archives of Gynecology and Obstetrics2 (2019): 271-276.
21. Vercellini P and Frattaruolo MP. "Adenomyosis: Clinical perspectives”. The Journal of Clinical Endocrinology and Metabolism7 (2014): 2632-2640.
22. Marnach ML and Westhoff CL. "The role of inflammation in abnormal uterine bleeding”. Obstetrics and Gynecology Clinics of North America3 (2013): 517-530.
23. Rodeghiero F and Castaman G. "Von Willebrand disease and bleeding disorders”. Blood Reviews3 (2014): 151-157.
24. McGowan J and McFadyen IR. "Platelet function disorders: A review”. British Journal of Haematology5 (2012): 657-670.
25. Rodriguez MS and Nasr F. "Vascular malformations of the uterus: A review of the literature”. American Journal of Roentgenology1 (2019): 138-147.
26. Shatz M and Fischer S. "Vascular dysfunction and its impact on abnormal uterine bleeding”. Current Opinion in Obstetrics and Gynecology4 (2014): 299-305.
27. van der Vleuten CJ and Mager JJ. "Menorrhagia in hereditary hemorrhagic telangiectasia”. The Journal of Maternal-Fetal and Neonatal Medicine15 (2017): 1786-1790.
28. Zeng Z and Chen Y. "Epidemiology of endometrial cancer: An overview”. The Journal of Obstetrics and Gynaecology Research 6 (2019): 1341-1349.
29. Arem H and Neuhouser ML. "Endometrial hyperplasia and cancer: Epidemiology and risk factors”. American Journal of Obstetrics and Gynecology1 (2013): 29-39.
30. McCluggage WG and Cossu A. "Menorrhagia and uterine cancer: A review”. Journal of Clinical Pathology6 (2019): 348-352.
31. ACOG Practice Bulletin. "Evaluation and management of abnormal uterine bleeding”. Obstetrics and Gynecology4 (2021): e182-e196.
32. Bansal SK and Yadav P. "Approach to the diagnosis of menorrhagia”. The Journal of Obstetrics and Gynecology of India4 (2020): 327-335.
33. MASD Shia M and MKIQ Ibrahim A. "Endometrial cancer: A review of the current management strategies”. American Journal of Cancer Research2 (2019): 182-193.